8-K - Replimune Group, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events . On October 20, 2025, Replimune Group, Inc. (the “Company”) issued a news release announcing that the U.S. Food and Drug Administration (the “FDA”

Other Event

9.01

Financial Statements and Exhibits . Exhibit No. Description 99.1 News Release dated October 20, 2025 104 Cover page interactive data file (formatted as Inline X

Exhibits Only

Source Document

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1